Autolus Therapeutics AUTL
NASDAQ AUTL
$1.24 -0.09 (-6.44%)
At close: Nov 11, 2026 · 4:00 PM EST

Autolus Therapeutics (AUTL) Gains (Losses) on Sale of Assets & Investments (2021 - 2025)

Updated

Autolus Therapeutics (AUTL) posted Non Operating Investment Income of -$3,000 for Q1 2025.

Analysis

Autolus Therapeutics (AUTL) Gains (Losses) on Sale of Assets & Investments (2021 - 2025) Analysis & Trends

For FY2024, Autolus Therapeutics' Non Operating Investment Income came in at -$223,000.

  • In prior years, Autolus Therapeutics' Non Operating Investment Income was -$3.79 million in FY2023, -$515,000 in FY2022 and -$676,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Autolus Therapeutics 468.91 Mn -511.27 Mn 23.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -3,000.00
Sep 30, 2024 -223,000.00
Jun 30, 2023 -23,000.00
Mar 31, 2023 -3.77 Mn
Dec 31, 2022 -515,000.00
Dec 31, 2021 -4,000.00
Mar 31, 2021 -672,000.00
API Access

Autolus Therapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=AUTL&period=max&api_key=YOUR_API_KEY